Bliss GVS Pharma Limited (BOM:506197)
India flag India · Delayed Price · Currency is INR
218.00
+3.70 (1.73%)
At close: Feb 12, 2026

Bliss GVS Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
23,06212,38611,7937,4217,97810,181
Market Cap Growth
35.15%5.03%58.92%-6.98%-21.63%-2.08%
Enterprise Value
21,93911,51111,4877,3147,89010,302
Last Close Price
218.00117.18111.8070.2675.3796.24
PE Ratio
21.3914.6915.6310.4753.0514.86
Forward PE
-6.576.576.576.576.57
PS Ratio
2.661.531.530.991.071.76
PB Ratio
1.971.131.180.810.941.23
P/TBV Ratio
2.051.191.230.850.981.27
P/FCF Ratio
-41.5015.83-12.9818.56
P/OCF Ratio
-11.7011.4721.635.8915.92
PEG Ratio
-0.290.290.290.290.29
EV/Sales Ratio
2.531.421.490.971.061.79
EV/EBITDA Ratio
15.889.427.776.316.779.88
EV/EBIT Ratio
20.3511.839.257.427.7911.52
EV/FCF Ratio
-38.5615.42-12.8318.78
Debt / Equity Ratio
0.050.080.100.110.130.15
Debt / EBITDA Ratio
0.380.700.660.870.921.14
Debt / FCF Ratio
-2.951.34-1.782.22
Net Debt / Equity Ratio
-0.13-0.05-0.040.04-0.030.07
Net Debt / EBITDA Ratio
-1.11-0.44-0.270.29-0.220.58
Net Debt / FCF Ratio
--1.78-0.54-0.56-0.421.10
Asset Turnover
-0.650.650.660.680.55
Inventory Turnover
-3.533.623.643.623.90
Quick Ratio
-3.453.552.382.322.66
Current Ratio
-4.815.153.613.333.76
Return on Equity (ROE)
-8.62%8.50%8.70%2.76%9.37%
Return on Assets (ROA)
-4.84%6.56%5.44%5.79%5.31%
Return on Invested Capital (ROIC)
7.19%6.98%9.06%8.05%5.06%7.37%
Return on Capital Employed (ROCE)
-8.60%11.80%10.20%11.60%10.20%
Earnings Yield
4.73%6.81%6.40%9.55%1.88%6.73%
FCF Yield
-2.41%6.32%-8.02%7.71%5.39%
Dividend Yield
0.46%0.43%0.45%0.71%0.66%0.52%
Payout Ratio
-6.46%7.15%7.67%35.41%8.10%
Buyback Yield / Dilution
-1.06%0.04%-0.56%-0.26%0.26%-2.26%
Total Shareholder Return
-0.82%0.46%-0.11%0.45%0.92%-1.74%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.